Brimonidine gel (Mirvaso®)

  • Traffic Light
    Grey
  • BNF
    13.6.3
  • Licensed Indicators
    Symptomatic treatment of facial erythema of rosacea patients
  • Reference
    APC May 14
  • Criteria
  • Provisional
    Yes

Do you want to add this to your CPD record?

Did you find this page helpful?